aluates Reports

$ 0.0

Automative

Global Mesalazine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-26U8899

BUY CHAPTERS

Global Mesalazine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-26U8899

Report

June 2025

Pages:157

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

PharmaZell GmbH

Syntese A/S

Chemi SPA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Cambrex Corporation

Mesalazine Market Size

In 2024, the global market size of Mesalazine was estimated to be worth US$ 186 million and is forecast to reach approximately US$ 239 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.

Mesalazine Market

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.

With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.

Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine.

The Mesalazine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesalazine market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mesalazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and regions.

Scope of Mesalazine Market Report

Report Metric	Details
Report Name	Mesalazine Market
Forecasted market size in 2031	approximately US$ 239 million
CAGR	3.7%
Forecasted years	2025 - 2031
Segment by Application	Tablets Capsules Pellet and Granule Suppository Enema Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Segment by Purity, Above 97 %, Above 98 %, Above 99 %
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Purity and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Mesalazine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mesalazine sales, revenue, price, gross margin, sales by region, by Purity, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Purity, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Purity, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Purity, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Purity, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Purity, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Purity, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Mesalazine Market size in 2031?

Ans: The Mesalazine Market size in 2031 will be approximately US$ 239 million.

What is the market share of major companies in Mesalazine Market?

Ans: The top 3 companies hold a share over 50%.

What is the Mesalazine Market share by region?

Ans: Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

What is the Segment by Purity share in Mesalazine Market?

Ans: Segment by Purity Above 97 %

Who are the main players in the Mesalazine Market report?

Ans: The main players in the Mesalazine Market are PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Segment by Purity, Above 97 %, Above 98 %, Above 99 %

What are the Application segmentation covered in the Mesalazine Market report?

Ans: The Applications covered in the Mesalazine Market report are Tablets, Capsules, Pellet and Granule, Suppository, Enema, Others

Recommended Reports

Bowel Disease Drugs

Sulfonamide & API

Inflammatory Treatment

1 Study Coverage

1.1 Mesalazine Product Introduction

1.2 Market by Purity

1.2.1 Global Mesalazine Market Size Growth Rate by Purity (2020 VS 2024 VS 2031)

1.2.2 Above 97 %

1.2.3 Above 98 %

1.2.4 Above 99 %

1.3 Market by Application

1.3.1 Global Mesalazine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Tablets

1.3.3 Capsules

1.3.4 Pellet and Granule

1.3.5 Suppository

1.3.6 Enema

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Mesalazine Market Size Estimates and Forecasts

2.1.1 Global Mesalazine Revenue 2020-2031

2.1.2 Global Mesalazine Sales 2020-2031

2.2 Mesalazine Market Size by Region: 2024 Versus 2031

2.3 Mesalazine Sales by Region (2020-2031)

2.3.1 Global Mesalazine Sales by Region: 2020-2025

2.3.2 Global Mesalazine Sales Forecast by Region (2026-2031)

2.3.3 Global Mesalazine Sales Market Share by Region (2020-2031)

2.4 Mesalazine Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Mesalazine Revenue by Region: 2020-2025

2.4.2 Global Mesalazine Revenue Forecast by Region (2026-2031)

2.4.3 Global Mesalazine Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Purity

3.1.1 Global Mesalazine Sales by Purity (2020-2031)

3.1.1.1 Global Mesalazine Sales Volume by Purity (2020-2031)

3.1.1.2 Global Mesalazine Sales Market Share by Purity (2020-2031)

3.1.2 Global Mesalazine Revenue by Purity (2020-2031)

3.1.2.1 Global Mesalazine Revenue by Purity (2020-2031)

3.1.2.2 Global Mesalazine Revenue Market Share by Purity (2020-2031)

3.1.3 Mesalazine Average Selling Price (ASP) by Purity (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Mesalazine Sales by Application (2020-2031)

3.2.1.1 Global Mesalazine Sales Volume by Application (2020-2031)

3.2.1.2 Global Mesalazine Sales Market Share by Application (2020-2031)

3.2.2 Global Mesalazine Revenue by Application (2020-2031)

3.2.2.1 Global Mesalazine Revenue by Application (2020-2031)

3.2.2.2 Global Mesalazine Revenue Market Share by Application (2020-2031)

3.2.3 Mesalazine Average Selling Price (ASP) by Application (2020-2031)

3.3 by Purity and by Application Crossing Analysis

3.3.1 Above 97 % of Mesalazine Revenue Market Share by Application

3.3.2 Above 98 % of Mesalazine Revenue Market Share by Application

3.3.3 Above 99 % of Mesalazine Revenue Market Share by Application

4 Global Mesalazine by Manufacturers

4.1 Global Top Mesalazine Manufacturers by Sales (2020-2025)

4.1.1 Global Mesalazine Sales by Manufacturer (2020-2025)

4.1.2 Global Mesalazine Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Mesalazine Manufacturers by Revenue (2020-2025)

4.2.1 Global Mesalazine Revenue by Manufacturer (2020-2025)

4.2.2 Global Mesalazine Revenue Share by Manufacturer (2020-2025)

4.3 Global Mesalazine Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Mesalazine Manufacturers Covered: Ranking by Revenue

4.4.2 Global Mesalazine Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Mesalazine Manufacturing Base Distribution, Product Type

4.5.1 Mesalazine Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Mesalazine Market

4.5.3 Manufacturers Mesalazine Product Type and Application

4.5.4 Above 97 % Market Sales of Mesalazine by Manufacturer

4.5.5 Above 98 % Market Sales of Mesalazine by Manufacturer

4.5.6 Above 99 % Market Sales of Mesalazine by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 PharmaZell

5.1.1 PharmaZell Company Information

5.1.2 PharmaZell Description, Business Overview

5.1.3 PharmaZell Mesalazine Products Offered

5.1.4 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.1.5 PharmaZell Mesalazine Sales by Product in 2024

5.1.6 PharmaZell Mesalazine Sales by Application in 2024

5.1.7 PharmaZell Mesalazine Sales by Geographic Area in 2024

5.1.8 PharmaZell Recent Developments

5.2 Syntese A/S

5.2.1 Syntese A/S Company Information

5.2.2 Syntese A/S Description, Business Overview

5.2.3 Syntese A/S Mesalazine Products Offered

5.2.4 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Syntese A/S Mesalazine Sales by Product in 2024

5.2.6 Syntese A/S Mesalazine Sales by Application in 2024

5.2.7 Syntese A/S Mesalazine Sales by Geographic Area in 2024

5.2.8 Syntese A/S Recent Developments

5.3 Cambrex Corporation

5.3.1 Cambrex Corporation Company Information

5.3.2 Cambrex Corporation Description, Business Overview

5.3.3 Cambrex Corporation Mesalazine Products Offered

5.3.4 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Cambrex Corporation Mesalazine Sales by Product in 2024

5.3.6 Cambrex Corporation Mesalazine Sales by Application in 2024

5.3.7 Cambrex Corporation Mesalazine Sales by Geographic Area in 2024

5.3.8 Cambrex Corporation Recent Developments

5.4 Divis Laboratories

5.4.1 Divis Laboratories Company Information

5.4.2 Divis Laboratories Description, Business Overview

5.4.3 Divis Laboratories Mesalazine Products Offered

5.4.4 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Divis Laboratories Mesalazine Sales by Product in 2024

5.4.6 Divis Laboratories Mesalazine Sales by Application in 2024

5.4.7 Divis Laboratories Mesalazine Sales by Geographic Area in 2024

5.4.8 Divis Laboratories Recent Developments

5.5 Chemi SpA

5.5.1 Chemi SpA Company Information

5.5.2 Chemi SpA Description, Business Overview

5.5.3 Chemi SpA Mesalazine Products Offered

5.5.4 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Chemi SpA Mesalazine Sales by Product in 2024

5.5.6 Chemi SpA Mesalazine Sales by Application in 2024

5.5.7 Chemi SpA Mesalazine Sales by Geographic Area in 2024

5.5.8 Chemi SpA Recent Developments

5.6 Ipca Laboratories

5.6.1 Ipca Laboratories Company Information

5.6.2 Ipca Laboratories Description, Business Overview

5.6.3 Ipca Laboratories Mesalazine Products Offered

5.6.4 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Ipca Laboratories Mesalazine Sales by Product in 2024

5.6.6 Ipca Laboratories Mesalazine Sales by Application in 2024

5.6.7 Ipca Laboratories Mesalazine Sales by Geographic Area in 2024

5.6.8 Ipca Laboratories Recent Developments

5.7 Hangzhou Brother

5.7.1 Hangzhou Brother Company Information

5.7.2 Hangzhou Brother Description, Business Overview

5.7.3 Hangzhou Brother Mesalazine Products Offered

5.7.4 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Hangzhou Brother Mesalazine Sales by Product in 2024

5.7.6 Hangzhou Brother Mesalazine Sales by Application in 2024

5.7.7 Hangzhou Brother Mesalazine Sales by Geographic Area in 2024

5.7.8 Hangzhou Brother Recent Developments

5.8 Lianyungang Fengheng Biopharm

5.8.1 Lianyungang Fengheng Biopharm Company Information

5.8.2 Lianyungang Fengheng Biopharm Description, Business Overview

5.8.3 Lianyungang Fengheng Biopharm Mesalazine Products Offered

5.8.4 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.8.5 Lianyungang Fengheng Biopharm Mesalazine Sales by Product in 2024

5.8.6 Lianyungang Fengheng Biopharm Mesalazine Sales by Application in 2024

5.8.7 Lianyungang Fengheng Biopharm Mesalazine Sales by Geographic Area in 2024

5.8.8 Lianyungang Fengheng Biopharm Recent Developments

5.9 Lasa Loboratory

5.9.1 Lasa Loboratory Company Information

5.9.2 Lasa Loboratory Description, Business Overview

5.9.3 Lasa Loboratory Mesalazine Products Offered

5.9.4 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.9.5 Lasa Loboratory Mesalazine Sales by Product in 2024

5.9.6 Lasa Loboratory Mesalazine Sales by Application in 2024

5.9.7 Lasa Loboratory Mesalazine Sales by Geographic Area in 2024

5.9.8 Lasa Loboratory Recent Developments

5.10 Corden Pharma Bergamo

5.10.1 Corden Pharma Bergamo Company Information

5.10.2 Corden Pharma Bergamo Description, Business Overview

5.10.3 Corden Pharma Bergamo Mesalazine Products Offered

5.10.4 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.10.5 Corden Pharma Bergamo Mesalazine Sales by Product in 2024

5.10.6 Corden Pharma Bergamo Mesalazine Sales by Application in 2024

5.10.7 Corden Pharma Bergamo Mesalazine Sales by Geographic Area in 2024

5.10.8 Corden Pharma Bergamo Recent Developments

5.11 Erregierre SpA

5.11.1 Erregierre SpA Company Information

5.11.2 Erregierre SpA Description, Business Overview

5.11.3 Erregierre SpA Mesalazine Products Offered

5.11.4 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.11.5 Erregierre SpA Mesalazine Sales by Product in 2024

5.11.6 Erregierre SpA Mesalazine Sales by Application in 2024

5.11.7 Erregierre SpA Mesalazine Sales by Geographic Area in 2024

5.11.8 Erregierre SpA Recent Developments

5.12 CTX Lifescience

5.12.1 CTX Lifescience Company Information

5.12.2 CTX Lifescience Description, Business Overview

5.12.3 CTX Lifescience Mesalazine Products Offered

5.12.4 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.12.5 CTX Lifescience Mesalazine Sales by Product in 2024

5.12.6 CTX Lifescience Mesalazine Sales by Application in 2024

5.12.7 CTX Lifescience Mesalazine Sales by Geographic Area in 2024

5.12.8 CTX Lifescience Recent Developments

5.13 Ishita Active Pharma Ingredients

5.13.1 Ishita Active Pharma Ingredients Company Information

5.13.2 Ishita Active Pharma Ingredients Description, Business Overview

5.13.3 Ishita Active Pharma Ingredients Mesalazine Products Offered

5.13.4 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.13.5 Ishita Active Pharma Ingredients Mesalazine Sales by Product in 2024

5.13.6 Ishita Active Pharma Ingredients Mesalazine Sales by Application in 2024

5.13.7 Ishita Active Pharma Ingredients Mesalazine Sales by Geographic Area in 2024

5.13.8 Ishita Active Pharma Ingredients Recent Developments

5.14 YC Biotech (Jiangsu)

5.14.1 YC Biotech (Jiangsu) Company Information

5.14.2 YC Biotech (Jiangsu) Description, Business Overview

5.14.3 YC Biotech (Jiangsu) Mesalazine Products Offered

5.14.4 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2020-2025)

5.14.5 YC Biotech (Jiangsu) Mesalazine Sales by Product in 2024

5.14.6 YC Biotech (Jiangsu) Mesalazine Sales by Application in 2024

5.14.7 YC Biotech (Jiangsu) Mesalazine Sales by Geographic Area in 2024

5.14.8 YC Biotech (Jiangsu) Recent Developments

6 North America

6.1 North America Mesalazine Market Size YoY Growth 2020-2031

6.2 North America Mesalazine Market Facts & Figures by Country

6.2.1 North America Mesalazine Sales by Country (2020-2031)

6.2.2 North America Mesalazine Revenue by Country (2020-2031)

6.3 North America Mesalazine Sales by Purity (2020-2025)

6.4 North America Mesalazine Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Mesalazine Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Mesalazine Market Facts & Figures by Region

7.2.1 Asia-Pacific Mesalazine Sales by Region (2020-2031)

7.2.2 Asia-Pacific Mesalazine Revenue by Region (2020-2031)

7.3 Asia-Pacific Mesalazine Sales by Purity (2020-2025)

7.4 Asia-Pacific Mesalazine Sales by Application (2020-2025)

8 Europe

8.1 Europe Mesalazine Market Size YoY Growth 2020-2031

8.2 Europe Mesalazine Market Facts & Figures by Country

8.2.1 Europe Mesalazine Sales by Country (2020-2031)

8.2.2 Europe Mesalazine Revenue by Country (2020-2031)

8.3 Europe Mesalazine Sales by Purity (2020-2025)

8.4 Europe Mesalazine Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Mesalazine Market Size YoY Growth 2020-2031

9.2 Latin America Mesalazine Market Facts & Figures by Country

9.2.1 Latin America Mesalazine Sales by Country (2020-2031)

9.2.2 Latin America Mesalazine Revenue by Country (2020-2031)

9.3 Latin America Mesalazine Sales by Purity (2020-2025)

9.4 Latin America Mesalazine Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Mesalazine Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Mesalazine Market Facts & Figures by Country

10.2.1 Middle East and Africa Mesalazine Sales by Country (2020-2031)

10.2.2 Middle East and Africa Mesalazine Revenue by Country (2020-2031)

10.3 Middle East and Africa Mesalazine Sales by Purity (2020-2025)

10.4 Middle East and Africa Mesalazine Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Mesalazine Supply Chain Analysis

11.2 Mesalazine Key Raw Materials and Upstream Suppliers

11.3 Mesalazine Clients Analysis

11.4 Mesalazine Sales Channel and Sales Model Analysis

11.4.1 Mesalazine Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Mesalazine Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Mesalazine Distributors

12 Mesalazine Market Dynamics

12.1 Mesalazine Industry Trends

12.2 Mesalazine Market Drivers

12.3 Mesalazine Market Challenges

12.4 Mesalazine Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

PharmaZell GmbH

Syntese A/S

Chemi SPA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Cambrex Corporation

List of Tables

Table 1. Global Mesalazine Market Size Growth Rate by Purity (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Mesalazine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Mesalazine Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Mesalazine Sales by Region (2020-2025) & (Tons)

Table 5. Global Mesalazine Sales Forecast by Region (2026-2031) & (Tons)

Table 6. Global Mesalazine Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Mesalazine Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Mesalazine Sales Volume by Purity (2020-2025) & (Tons)

Table 9. Global Mesalazine Sales Volume by Purity (2026-2031) & (Tons)

Table 10. Global Mesalazine Revenue by Purity (2020-2025) & (US$ Million)

Table 11. Global Mesalazine Revenue Forecast by Purity (2026-2031) & (US$ Million)

Table 12. Global Mesalazine Sales Volume by Application (2020-2025) & (Tons)

Table 13. Global Mesalazine Sales Volume by Application (2026-2031) & (Tons)

Table 14. Global Mesalazine Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Mesalazine Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Mesalazine Sales by Manufacturer (2020-2025) & (Tons)

Table 17. Global Mesalazine Sales Share by Manufacturer (2020-2025)

Table 18. Mesalazine Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Mesalazine Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Mesalazine Price (2020-2025) & (US$/kg)

Table 21. Ranking of Global Top Mesalazine Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Mesalazine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Mesalazine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine as of 2024)

Table 24. Mesalazine Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Mesalazine Market

Table 26. Manufacturers Mesalazine Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. PharmaZell Company Information

Table 29. PharmaZell Description and Business Overview

Table 30. PharmaZell Mesalazine Product

Table 31. PharmaZell Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 32. PharmaZell Sales Proportion of Mesalazine by Product in 2024

Table 33. PharmaZell Sales Proportion of Mesalazine by Application in 2024

Table 34. PharmaZell Sales Proportion of Mesalazine by Geographic Area in 2024

Table 35. PharmaZell Recent Developments

Table 36. Syntese A/S Company Information

Table 37. Syntese A/S Description and Business Overview

Table 38. Syntese A/S Mesalazine Product

Table 39. Syntese A/S Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 40. Syntese A/S Sales Proportion of Mesalazine by Product in 2024

Table 41. Syntese A/S Sales Proportion of Mesalazine by Application in 2024

Table 42. Syntese A/S Sales Proportion of Mesalazine by Geographic Area in 2024

Table 43. Syntese A/S Recent Developments

Table 44. Cambrex Corporation Company Information

Table 45. Cambrex Corporation Description and Business Overview

Table 46. Cambrex Corporation Mesalazine Product

Table 47. Cambrex Corporation Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 48. Cambrex Corporation Sales Proportion of Mesalazine by Product in 2024

Table 49. Cambrex Corporation Sales Proportion of Mesalazine by Application in 2024

Table 50. Cambrex Corporation Sales Proportion of Mesalazine by Geographic Area in 2024

Table 51. Cambrex Corporation Recent Developments

Table 52. Divis Laboratories Company Information

Table 53. Divis Laboratories Description and Business Overview

Table 54. Divis Laboratories Mesalazine Product

Table 55. Divis Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 56. Divis Laboratories Sales Proportion of Mesalazine by Product in 2024

Table 57. Divis Laboratories Sales Proportion of Mesalazine by Application in 2024

Table 58. Divis Laboratories Sales Proportion of Mesalazine by Geographic Area in 2024

Table 59. Divis Laboratories Recent Developments

Table 60. Chemi SpA Company Information

Table 61. Chemi SpA Description and Business Overview

Table 62. Chemi SpA Mesalazine Product

Table 63. Chemi SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 64. Chemi SpA Sales Proportion of Mesalazine by Product in 2024

Table 65. Chemi SpA Sales Proportion of Mesalazine by Application in 2024

Table 66. Chemi SpA Sales Proportion of Mesalazine by Geographic Area in 2024

Table 67. Chemi SpA Recent Developments

Table 68. Ipca Laboratories Company Information

Table 69. Ipca Laboratories Description and Business Overview

Table 70. Ipca Laboratories Mesalazine Product

Table 71. Ipca Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 72. Ipca Laboratories Sales Proportion of Mesalazine by Product in 2024

Table 73. Ipca Laboratories Sales Proportion of Mesalazine by Application in 2024

Table 74. Ipca Laboratories Sales Proportion of Mesalazine by Geographic Area in 2024

Table 75. Ipca Laboratories Recent Developments

Table 76. Hangzhou Brother Company Information

Table 77. Hangzhou Brother Description and Business Overview

Table 78. Hangzhou Brother Mesalazine Product

Table 79. Hangzhou Brother Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 80. Hangzhou Brother Sales Proportion of Mesalazine by Product in 2024

Table 81. Hangzhou Brother Sales Proportion of Mesalazine by Application in 2024

Table 82. Hangzhou Brother Sales Proportion of Mesalazine by Geographic Area in 2024

Table 83. Hangzhou Brother Recent Developments

Table 84. Lianyungang Fengheng Biopharm Company Information

Table 85. Lianyungang Fengheng Biopharm Description and Business Overview

Table 86. Lianyungang Fengheng Biopharm Mesalazine Product

Table 87. Lianyungang Fengheng Biopharm Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 88. Lianyungang Fengheng Biopharm Sales Proportion of Mesalazine by Product in 2024

Table 89. Lianyungang Fengheng Biopharm Sales Proportion of Mesalazine by Application in 2024

Table 90. Lianyungang Fengheng Biopharm Sales Proportion of Mesalazine by Geographic Area in 2024

Table 91. Lianyungang Fengheng Biopharm Recent Developments

Table 92. Lasa Loboratory Company Information

Table 93. Lasa Loboratory Description and Business Overview

Table 94. Lasa Loboratory Mesalazine Product

Table 95. Lasa Loboratory Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 96. Lasa Loboratory Sales Proportion of Mesalazine by Product in 2024

Table 97. Lasa Loboratory Sales Proportion of Mesalazine by Application in 2024

Table 98. Lasa Loboratory Sales Proportion of Mesalazine by Geographic Area in 2024

Table 99. Lasa Loboratory Recent Developments

Table 100. Corden Pharma Bergamo Company Information

Table 101. Corden Pharma Bergamo Description and Business Overview

Table 102. Corden Pharma Bergamo Mesalazine Product

Table 103. Corden Pharma Bergamo Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 104. Corden Pharma Bergamo Sales Proportion of Mesalazine by Product in 2024

Table 105. Corden Pharma Bergamo Sales Proportion of Mesalazine by Application in 2024

Table 106. Corden Pharma Bergamo Sales Proportion of Mesalazine by Geographic Area in 2024

Table 107. Corden Pharma Bergamo Recent Developments

Table 108. Erregierre SpA Company Information

Table 109. Erregierre SpA Description and Business Overview

Table 110. Erregierre SpA Mesalazine Product

Table 111. Erregierre SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 112. Erregierre SpA Sales Proportion of Mesalazine by Product in 2024

Table 113. Erregierre SpA Sales Proportion of Mesalazine by Application in 2024

Table 114. Erregierre SpA Sales Proportion of Mesalazine by Geographic Area in 2024

Table 115. Erregierre SpA Recent Developments

Table 116. CTX Lifescience Company Information

Table 117. CTX Lifescience Description and Business Overview

Table 118. CTX Lifescience Mesalazine Product

Table 119. CTX Lifescience Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 120. CTX Lifescience Sales Proportion of Mesalazine by Product in 2024

Table 121. CTX Lifescience Sales Proportion of Mesalazine by Application in 2024

Table 122. CTX Lifescience Sales Proportion of Mesalazine by Geographic Area in 2024

Table 123. CTX Lifescience Recent Developments

Table 124. Ishita Active Pharma Ingredients Company Information

Table 125. Ishita Active Pharma Ingredients Description and Business Overview

Table 126. Ishita Active Pharma Ingredients Mesalazine Product

Table 127. Ishita Active Pharma Ingredients Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 128. Ishita Active Pharma Ingredients Sales Proportion of Mesalazine by Product in 2024

Table 129. Ishita Active Pharma Ingredients Sales Proportion of Mesalazine by Application in 2024

Table 130. Ishita Active Pharma Ingredients Sales Proportion of Mesalazine by Geographic Area in 2024

Table 131. Ishita Active Pharma Ingredients Recent Developments

Table 132. YC Biotech (Jiangsu) Company Information

Table 133. YC Biotech (Jiangsu) Description and Business Overview

Table 134. YC Biotech (Jiangsu) Mesalazine Product

Table 135. YC Biotech (Jiangsu) Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 136. YC Biotech (Jiangsu) Sales Proportion of Mesalazine by Product in 2024

Table 137. YC Biotech (Jiangsu) Sales Proportion of Mesalazine by Application in 2024

Table 138. YC Biotech (Jiangsu) Sales Proportion of Mesalazine by Geographic Area in 2024

Table 139. YC Biotech (Jiangsu) Recent Developments

Table 140. North America Mesalazine Sales by Country (2020-2025) & (Tons)

Table 141. North America Mesalazine Sales by Country (2026-2031) & (Tons)

Table 142. North America Mesalazine Revenue by Country (2020-2025) & (US$ Million)

Table 143. North America Mesalazine Revenue by Country (2026-2031) & (US$ Million)

Table 144. North America Mesalazine Sales by Purity (2020-2025) & (Tons)

Table 145. North America Mesalazine Sales by Application (2020-2025) & (Tons)

Table 146. Asia-Pacific Mesalazine Sales by Region (2020-2025) & (Tons)

Table 147. Asia-Pacific Mesalazine Sales by Region (2026-2031) & (Tons)

Table 148. Asia-Pacific Mesalazine Revenue by Region (2020-2025) & (US$ Million)

Table 149. Asia-Pacific Mesalazine Revenue by Region (2026-2031) & (US$ Million)

Table 150. Asia-Pacific Mesalazine Sales by Purity (2020-2025) & (Tons)

Table 151. Asia-Pacific Mesalazine Sales by Application (2020-2025) & (Tons)

Table 152. Europe Mesalazine Sales by Country (2020-2025) & (Tons)

Table 153. Europe Mesalazine Sales by Country (2026-2031) & (Tons)

Table 154. Europe Mesalazine Revenue by Country (2020-2025) & (US$ Million)

Table 155. Europe Mesalazine Revenue by Country (2026-2031) & (US$ Million)

Table 156. Europe Mesalazine Sales by Purity (2020-2025) & (Tons)

Table 157. Europe Mesalazine Sales by Application (2020-2025) & (Tons)

Table 158. Latin America Mesalazine Sales by Country (2020-2025) & (Tons)

Table 159. Latin America Mesalazine Sales by Country (2026-2031) & (Tons)

Table 160. Latin America Mesalazine Revenue by Country (2020-2025) & (US$ Million)

Table 161. Latin America Mesalazine Revenue by Country (2026-2031) & (US$ Million)

Table 162. Latin America Mesalazine Sales by Purity (2020-2025) & (Tons)

Table 163. Latin America Mesalazine Sales by Application (2020-2025) & (Tons)

Table 164. Middle East and Africa Mesalazine Sales by Country (2020-2025) & (Tons)

Table 165. Middle East and Africa Mesalazine Sales by Country (2026-2031) & (Tons)

Table 166. Middle East and Africa Mesalazine Revenue by Country (2020-2025) & (US$ Million)

Table 167. Middle East and Africa Mesalazine Revenue by Country (2026-2031) & (US$ Million)

Table 168. Middle East and Africa Mesalazine Sales by Purity (2020-2025) & (Tons)

Table 169. Middle East and Africa Mesalazine Sales by Application (2020-2025) & (Tons)

Table 170. Mesalazine Key Raw Materials, Industry Status and Trend

Table 171. Mesalazine Key Raw Materials and Upstream Suppliers

Table 172. Mesalazine Clients Status and Trend

Table 173. Mesalazine Typical Clients

Table 174. Mesalazine Distributors

Table 175. Mesalazine Market Trends

Table 176. Mesalazine Market Drivers

Table 177. Mesalazine Market Challenges

Table 178. Mesalazine Market Restraints

Table 179. Research Programs/Design for This Report

Table 180. Key Data Information from Secondary Sources

Table 181. Key Data Information from Primary Sources

Table 182. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Mesalazine Product Picture

Figure 2. Global Mesalazine Market Size by Purity (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Mesalazine Sales Market Share by Purity in 2024 & 2031

Figure 4. Above 97 % Product Picture

Figure 5. Above 98 % Product Picture

Figure 6. Above 99 % Product Picture

Figure 7. Global Mesalazine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Mesalazine Sales Market Share by Application in 2024 & 2031

Figure 9. Tablets

Figure 10. Capsules

Figure 11. Pellet and Granule

Figure 12. Suppository

Figure 13. Enema

Figure 14. Others

Figure 15. Mesalazine Report Years Considered

Figure 16. Global Mesalazine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Mesalazine Market Size 2020-2031 (US$ Million)

Figure 18. Global Mesalazine Sales 2020-2031 (Tons)

Figure 19. Global Mesalazine Sales Market Share Forecast by Region (2020-2031)

Figure 20. Global Mesalazine Revenue Market Share by Region (2020-2031)

Figure 21. Global Mesalazine Sales Market Share Forecast by Purity (2020-2031)

Figure 22. Global Mesalazine Revenue Market Share Forecast by Purity (2020-2031)

Figure 23. Mesalazine Average Selling Price (ASP) by Purity (2020-2025) & (US$/kg)

Figure 24. Global Mesalazine Sales Market Share Forecast by Application (2020-2031)

Figure 25. Global Mesalazine Revenue Market Share Forecast by Application (2020-2031)

Figure 26. Mesalazine Average Selling Price (ASP) by Application (2020-2025) & (US$/kg)

Figure 27. Above 97 % of Mesalazine Revenue Market Share by Application, 2024 VS 2031

Figure 28. Above 98 % of Mesalazine Revenue Market Share by Application, 2024 VS 2031

Figure 29. Above 99 % of Mesalazine Revenue Market Share by Application, 2024 VS 2031

Figure 30. Global Mesalazine Sales Share by Manufacturer in 2024

Figure 31. Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 32. Above 97 % Market Sales Proportion by Manufacturer in 2024

Figure 33. Above 98 % Market Sales Proportion by Manufacturer in 2024

Figure 34. Above 99 % Market Sales Proportion by Manufacturer in 2024

Figure 35. North America Mesalazine Revenue 2020-2031 (US$ Million)

Figure 36. North America Mesalazine Sales Market Share by Purity (2020-2025)

Figure 37. North America Mesalazine Sales Market Share by Application (2020-2025)

Figure 38. Asia-Pacific Mesalazine Revenue 2020-2031 (US$ Million)

Figure 39. Asia-Pacific Mesalazine Sales Market Share by Region (2020-2031)

Figure 40. Asia-Pacific Mesalazine Revenue Market Share by Region (2020-2031)

Figure 41. Asia-Pacific Mesalazine Sales Market Share by Purity (2020-2025)

Figure 42. Asia-Pacific Mesalazine Sales Market Share by Application (2020-2025)

Figure 43. Europe Mesalazine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 44. Europe Mesalazine Sales Market Share by Country (2020-2031)

Figure 45. Europe Mesalazine Revenue Market Share by Country (2020-2031)

Figure 46. Europe Mesalazine Sales Market Share by Purity (2020-2025)

Figure 47. Europe Mesalazine Sales Market Share by Application (2020-2025)

Figure 48. Latin America Mesalazine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 49. Latin America Mesalazine Sales Market Share by Country (2020-2031)

Figure 50. Latin America Mesalazine Revenue Market Share by Country (2020-2025)

Figure 51. Latin America Mesalazine Sales Market Share by Purity (2020-2025)

Figure 52. Latin America Mesalazine Sales Market Share by Application (2020-2025)

Figure 53. Middle East and Africa Mesalazine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 54. Middle East and Africa Mesalazine Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Mesalazine Revenue Market Share by Country (2020-2031)

Figure 56. Middle East and Africa Mesalazine Sales Market Share by Purity (2020-2025)

Figure 57. Middle East and Africa Mesalazine Sales Market Share by Application (2020-2025)

Figure 58. Mesalazine Supply Chain (Upstream and Downstream Market)

Figure 59. Global Production Market Share of Mesalazine Raw Materials by Region in 2024

Figure 60. Mesalazine Distribution Channels

Figure 61. Global Mesalazine Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 62. Global Mesalazine Percentage 2020-2031: Online Sales VS Offline Sales

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oral Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesalamine Market Research Report 2024

Global Mesalamine API Market Research Report 2024

Rectal Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesalazine Suppositories Market Research Report 2024

5 aminosalicylic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mesalamine Lialda Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug for Ulcerative Colitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ulcerative Colitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ulcerative Colitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Balsalazide Disodium Market Research Report 2025

Global Aminosalicylic Acid Preparation Market Insights Forecast to 2030

Global Adalimumab Market Insights Forecast to 2030

Global Small Molecules Drugs for Inflammatory Bowel Diseases IBDs Market Research Report 2024

Global Sodium 4 Aminosalicylate Market Research Report 2024

Vesanoid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesalazine Enteric Coated Tablets Market Research Report 2024

Global Sulfadimidine and Sodium Salt Market Research Report 2024

Global Humira Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions